Avanos Medical, Inc. (AVNS) The Citizens Life Sciences Conference 2026 March 11, 2026 1:05 PM EDT
Company Participants
David Pacitti – CEO & Director
Scott Galovan – CFO & Senior VP
Conference Call Participants
Daniel Stauder – Citizens JMP Securities, LLC, Research Division
Presentation
Daniel Stauder
Citizens JMP Securities, LLC, Research Division
So welcome back to the Citizens Life Sciences Conference. Next up on our MedTech track, we’re joined by Avanos Medical. With us here is CEO, Dave Pacitti; and CFO, Scott Galovan. Gentlemen, thanks for coming. Welcome to Miami.
David Pacitti
CEO & Director
Thank you.
Question-and-Answer Session
Daniel Stauder
Citizens JMP Securities, LLC, Research Division
Great. So I guess just to start off, Dave, you’re approaching your 1-year anniversary at the helm. So I just want to give you the opportunity to give your high-level thoughts. What do you think has gone well? What surprised you? What’s been a challenge — you want to take it?
David Pacitti
CEO & Director
Yes, absolutely. So we’ve been excited. We’ve been very focused on execution, as you know. Part of that execution was a cost takeout that we did back in December, really streamlined the business.
I would say what was surprising to me this year is how much time we spent on tariffs, right? And we talked to you a lot about that as well. And we see the light at the end of the tunnel, and it’s not a train, which is good. A big part of our tariff situation was around syringe products that we made in China. We’ll be out of China by June. It’s actually going quite well. We feel like we’re ahead of schedule. We’re producing those syringes now in Mexico and Cambodia. We’re not selling them yet from there, but the fact that we’re producing them is really good. So that’s been a big part of our